Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023

المصدر: Nasdaq GlobeNewswire / 23 أكتوبر 2023 07:07:01   America/Chicago